Rinomicine

Rinomicine belongs to Biopharm Group through Laboratoires Biopharm. Rinomicine is owned by Biopharm Group, headquartered in Algeria. No. The ultimate owner of Rinomicine, Biopharm Group, is headquartered in Algeria, not in the United States.

Biopharm is a leading Algerian pharmaceutical company engaged in the development, production, and distribution of medicines.